INDP Indaptus Therapeutics, Inc.
$3.31▲ +0.15%
Healthcare
Other
Volume 128.0K
Avg Volume (10D) 442.6K
Key Metrics & Fundamentals
Market Cap
$441.03M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.92 - 5.96
% vs 50 MA
36.75%
% vs 200 MA
44.47%
RSI-14
59.2
MACD Histogram
+0.0600
Beta (1Y vs SPY)
1.93
Free Cash Flow
-$1.93M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$1.81M
COGS
–
Operating Exp
$1.81M
Operating Income
-$1.81M
EBIT
-$1.81M
Pretax Income
-$1.79M
Net Income
-$1.79M
EPS (Diluted)
-0.02
Price & Volume History
Loading chart…
Recent News
MRNA On Track To Be September's No. 2 S&P 500 Stock — But These 5 Smaller Health Care Names Did Even Better
Stocktwits · Sep 24, 2026 11:23 PM ET
Indaptus Therapeutics Shares Rise After Entering $24 Million Private Placement
MT Newswires · Sep 10, 2026 3:20 PM ET
Indaptus Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire · Aug 13, 2026 7:00 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See INDP's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.